23 devices · GMDN 50265
Rubella virus immunoglobulin G (IgG) antibody IVD kits use an enzyme immunoassay to detect the presence and amount of IgG antibodies against rubella in patient samples. These kits are employed in clinical laboratories to confirm past infection, assess immunity, or support diagnosis of rubella exposure.
These products are in‑vitro diagnostic (IVD) kits composed of reagents, controls and instructions that must comply with the regulatory framework governing IVD devices in each market. They are typically supplied as a single, ready‑to‑use kit and are subject to the applicable conformity assessment procedures before they can be marketed.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.